Analysis – Goldea Capital

eToro Acquires Zengo to Expand Self-Custodial Crypto Capabilities

Written by Customer Service on April 15, 2026. Posted in Mergers And Acquisitions.

NEW YORK, April 15, 2026 (GLOBE NEWSWIRE) — eToro, the trading and investing platform, has entered into an agreement to acquire Zengo, a leading self-custodial crypto wallet provider, in a move that deepens eToro’s digital asset capabilities and accelerates its strategy of connecting traditional finance with on-chain infrastructure and the crypto native economy. The acquisition brings together eToro’s global multi-asset platform and distribution with Zengo’s non-custodial wallet technology, supporting Zengo’s next phase of growth while expanding eToro’s digital asset capabilities. The transaction strengthens eToro’s ability to support evolving digital asset use cases, including tokenized assets and emerging decentralized trading models such as prediction markets and perpetuals, as these markets develop. Yoni Assia, Co-founder and...

Ongwe Minerals Announces Listing on the Namibia Securities Exchange

Written by Customer Service on April 15, 2026. Posted in Public Companies.

VANCOUVER, British Columbia, April 15, 2026 (GLOBE NEWSWIRE) — Ongwe Minerals Inc. (“Ongwe” or “the Company”) (TSXV: OGW) (NSX: ONG) is pleased to announce that the Company has completed all the requirements for a dual-listing on the Namibia Securities Exchange (“NSX”) under the symbol “ONG”, with trading to commence on 15 April 2026. There will be no change to Ongwe’s listing on the TSX Venture Exchange which will remain the primary listing for Ongwe’s common shares. Dave Underwood, Ongwe’s CEO commented: “The dual listing of Ongwe on the Namibian Securities Exchange is a very important step in building Ongwe’s local Namibian capital markets presence. Ongwe is fortunate to have a dedicated and substantial base of Namibian shareholders, many of whom have shared in the prior successes of the Ongwe team, through Osino Resources and...

Trident Intersects 4.61 g/t Au over 38.48m from 77.00m, including 5.48 g/t over 26.14m from Hole 26028 – 200m ENE of 2025 Drilling. Hole 26025 intersects 11.97 g/t over 10.70m from 324.20m at Contact Lake, Expands Winter Drill Program

Written by Customer Service on April 15, 2026. Posted in Public Companies.

Vancouver, BC, April 15, 2026 (GLOBE NEWSWIRE) — Trident Resources Corp. (TSXV: ROCK) (OTCQB: TRDTF) (“Trident” or the “Company”) is pleased to announce assay results for the first 9 (nine) diamond drill holes from the ongoing 2026 winter drill program at the Contact Lake Gold Project in northern Saskatchewan. Hole CL26028 returned high-grade gold values from numerous broad zones within the Bakos Shear zone. This mineralization was discovered over 200m ENE from high-grade gold reported in hole CL25003 from Trident’s 2025 fall drill program (previously reported CL 25003 intersected 7.03 g/t over 43.25m from 121.00m; Trident Resources Corp. – News). The Company has decided to increase this winter phase of drilling from 10,000m to 13,000m. Trident’s Regional Project Location Map:https://www.tridentresourcescorp.com/projects/contact-lake-gold-project/#&gid=1&pid=1 The...

Notice on the Supplement to the Agenda of the Ordinary General Meeting of Shareholders of Vilkyškių pieninė AB to be held on 27 April 2026

Written by Customer Service on April 15, 2026. Posted in Public Companies.

Vilkyškių pieninė AB (company code 277160980, registered office address: P. Lukošaičio g. 14, Vilkyškiai, LT-99254 Pagėgiai municipality, hereinafter – the Company) hereby supplements the agenda of the ordinary general meeting of shareholders to be held on 27 April 2026 by splitting agenda item 3 “Regarding agreement of the Company’s 2025 consolidated and separate annual management report” into two separate items:3. Regarding agreement of the Company’s 2025 separate and consolidated annual management report, excluding information on remuneration.4. Regarding agreement of the Company’s information on remuneration as part of the Company’s 2025 consolidated annual management report. SUPPLEMENTED AGENDA OF THE ORDINARY GENERAL MEETING OF SHAREHOLDERS:Regarding the independent auditor’s report on the Company’s 2025 separate and...

Notice of Issuance of New Shares in Connection with the Introduction of the Employee Stock Ownership Plan, Matters Relating to Stock Units and Determination of Payment Amount and Other Matters of Issuance of New Shares Under Prior RSU Award

Written by Customer Service on April 15, 2026. Posted in Public Companies.

Tokyo, Japan and Cambridge, UK, 15 April 2026 – Nxera Pharma Co. Ltd (“Nxera” or the “Company”; TSE 4565) announces that, in connection with the introduction of the Employee Stock Ownership Plan for employees residing in Japan (“J-ESOP”), as announced on 19 November 2025, it has resolved to issue new shares of the Company (the “J-ESOP Share Issuance”) as set out below. The J-ESOP Share Issuance is intended to secure the shares required for the operation of J-ESOP, including in connection with the transition to J-ESOP of certain outstanding Restricted Stock Units (“RSUs”) previously granted to employees of the Company and its wholly owned subsidiary Nxera Pharma Japan Co., Ltd. (together “Nxera Japan”) residing in Japan (“Outstanding Equity Awards”), for which the payment date or payment period has not yet arrived, and does...

CLINUVEL: advancing peptides for photomedicine and vitiligo care at AAD 2026

Written by Customer Service on April 15, 2026. Posted in Public Companies.

AAD 2026 reinforces CLINUVEL’s expertise in dermatologyStep inside CLINUVEL’s Pavilion of Photomedicine and experience the energy of AAD 2026 through an exclusive video featuring behind-the-scenes of construction, expert insights from the CLINUVEL team and immersive visuals of guests engaging within the Pavilion.MELBOURNE, Australia, April 15, 2026 (GLOBE NEWSWIRE) — CLINUVEL’s innovative photomedicine and vitiligo programs featured extensively at the recent American Academy of Dermatology (AAD) Annual Meeting, the world’s largest gathering of dermatology professionals. Through the Company’s bespoke Pavilion of Photomedicine and conference sessions across five days, the development and commercialisation of CLINUVEL’s proprietary peptides in dermatology was presented to over 20,000 delegates. Building on momentum...

Stellantis Reports Q1 2026 Estimated Consolidated Shipments of 1.4 Million Units, +12% y-o-y

Written by Customer Service on April 15, 2026. Posted in Earnings Releases And Operating Results.

Stellantis Reports Q1 2026 Estimated Consolidated Shipments of 1.4 Million Units, +12% y-o-yGrowth in all regions, led by North America and Enlarged EuropeAMSTERDAM, April 15, 2026 – Stellantis N.V. today released its Q1 2026 estimated consolidated shipments. The term “shipments” describes the volume of vehicles delivered to dealers, distributors, or directly from the Company to retail and fleet customers, which generally drive revenue recognition. Consolidated shipments for the three months ending March 31, 2026, were an estimated 1.4 million units, up 12% y-o-y. This increase was primarily driven by Enlarged Europe and North America, and further supported by year‑over‑year shipments growth in Middle East & Africa and South America. In North America, Q1 shipments grew by approximately 54 thousand units compared to the same...

Convocation to the ordinary general shareholders’ meeting of 18 May 2026

Written by Customer Service on April 15, 2026. Posted in Earnings Releases And Operating Results.

PRESS RELEASE REGULATED INFORMATION Brussels, 15 April 2026, 7.55 am Convocation to the ordinary general shareholders’ meeting of 18 May 2026 The board of directors of Nextensa invites the shareholders to attend the ordinary general shareholders’ meeting that will be held on Monday 18 May 2026 at Maison de la Poste, Picardstraat 5 box 7, 1000 Brussels. The ordinary general meeting will commence at 4:00 PM The documents relating to these shareholders’ meeting are available from today on the website www.nextensa.eu under the heading ‘Investors’ – ‘General meetings’. For more information Michel Van Geyte | Chief Executive Officer Nextensa NV/SA | 0436.323.915 (RLE Brussels, Dutch-speaking division) Gare Maritime, Picardstraat 11, B505, 1000 Brussels +32...

OSE Immunotherapeutics to Present a Novel, First-in-Class, FPR2 Agonist Monoclonal Antibody in the Resolution of Chronic Inflammation at the AAI 2026 Meeting

Written by Customer Service on April 15, 2026. Posted in Public Companies.

Nantes, France, April 15, 2026 – 7:30am CEST – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), a clinical-stage biotech company dedicated to developing first-in-class therapies in immuno-oncology and immuno-inflammation, today announced that an abstract on a novel agonist monoclonal antibody targeting FPR2, a key receptor involved in the triggering resolution of inflammation, has been selected for an oral presentation at the 2026 Annual Meeting of the American Association of Immunologists (AAI) in Boston, Massachusetts, United States (April 15-19, 2026). Aurore Morello, PhD, Chief Scientific Officer of OSE Immunotherapeutics, will unveil for the first time a novel, first‑in‑class therapeutic strategy targeting the FPR2 G‑protein–coupled receptor (GPCR). This approach aims to activate the body’s natural inflammation‑resolution...

Tryg A/S – Interim report Q1 2026

Written by Customer Service on April 15, 2026. Posted in Earnings Releases And Operating Results.

Tryg’s Supervisory Board has today approved the interim report for Q1 2026. Tryg reported a strong insurance service result of DKK 1,655m (DKK 1,540m) and a combined ratio of 84.0% (84.2%) in Q1 2026. The higher insurance service result was supported by an underlying claims ratio improvement of 40 basis points (up from 30 bps), including solid trends in Norway and a premium growth of 3.5% (3.7%) in local currencies. The investment result was DKK 2m (DKK 320m), showcasing the strength of Tryg’s low-risk investment approach in volatile markets. Pre-tax profit was DKK 1,276m (DKK 1,491m) and profit after tax was DKK 958m (DKK 1,118m). Ordinary dividend of DKK 2.15 (DKK 2.05) per share for the year is an increase of around 5% from the previous year. The reported solvency ratio at the end of Q1 2026 was 192% (196% Q4 2025), supportive...

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals